Intra-Cellular Therapies, Inc.

D. E. Shaw & Co., Inc.

Report date

3/31/2025

Quarter

2025 Q1

Filed

5/15/2025

Shares

923,809

Value ($000)

121,869

Weight

0.1%

2019 Q4 - 2025 Q1 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	5/15/2025	121,869	0.1%	923,809	3/31/2025
2024 Q4	2/14/2025	44,638	0.0%	534,461	12/31/2024
2024 Q3	11/14/2024	26,976	0.0%	368,680	9/30/2024
2024 Q2	8/14/2024	39,749	0.1%	580,359	6/30/2024
2023 Q4	2/14/2024	36,637	0.1%	511,550	12/31/2023
2023 Q3	11/14/2023	38,618	0.1%	741,377	9/30/2023
2023 Q2	8/14/2023	60,334	0.1%	952,842	6/30/2023
2023 Q1	5/15/2023	27,611	0.0%	509,904	3/31/2023
2022 Q4	2/14/2023	27,174	0.0%	513,500	12/31/2022
2022 Q3	11/14/2022	16,289	0.0%	350,078	9/30/2022
2022 Q2	8/15/2022	19,331	0.0%	338,661	6/30/2022
2022 Q1	5/16/2022	22,311	0.0%	364,618	3/31/2022
2021 Q4	2/14/2022	8,039	0.0%	153,587	12/31/2021
2021 Q2	8/16/2021	1,962	0.0%	48,063	6/30/2021
2021 Q1	5/17/2021	4,072	0.0%	119,999	3/31/2021
2020 Q4	2/16/2021	3,113	0.0%	97,903	12/31/2020
2020 Q3	11/16/2020	5,892	0.0%	229,603	9/30/2020
2020 Q2	8/14/2020	4,648	0.0%	181,085	6/30/2020
2020 Q1	5/15/2020	2,866	0.0%	186,447	3/31/2020
2019 Q4	2/14/2020	7,940	0.0%	231,413	12/31/2019